Harrisons Manual of Oncology 2/E
Description:
Publisher's Note: Products purchased from Third Party sellers are not guaranteed by the publisher for quality, authenticity, or access to any online entitlements included with the product.
A CONCISE YET THOROUGH OVERVIEW OF THE MEDICATIONS AND APPROACHES USED IN CANCER CARE--BACKED BY THE AUTHORITY OF HARRISON'S
Harrison's Manual of Oncology is a carry-anywhere guide to the care of patients with cancer. Enhanced by the latest published results, this valuable clinical companion features numerous tables and succinct, outline-style text that puts important information at your fingertips. You will find content that goes beyond the treatment of primary or metastatic disease to encompass the treatment of all therapeutic complications.
The opening sections of Harrison's Manual of Oncology are devoted to the classes of agents used to treat cancer and reviews their pharmacology and mechanisms of action. This section is followed by a detailed discussion of the diagnosis, staging, and treatment of all major types of cancer. There is a strong focus on symptom management and complications of treatment, including pain, nausea and vomiting, anemia, febrile neutropenia, metabolicemergencies, thrombosis, psychological issues, and end-of-life care.
Best prices to buy, sell, or rent ISBN 9780071793254
Frequently Asked Questions about Harrisons Manual of Oncology 2/E
The price for the book starts from $7.83 on Amazon and is available from 17 sellers at the moment.
If you’re interested in selling back the Harrisons Manual of Oncology 2/E book, you can always look up BookScouter for the best deal. BookScouter checks 30+ buyback vendors with a single search and gives you actual information on buyback pricing instantly.
As for the Harrisons Manual of Oncology 2/E book, the best buyback offer comes from and is $ for the book in good condition.
The Harrisons Manual of Oncology 2/E book is in very low demand now as the rank for the book is 769,605 at the moment. It's a very low rank, and the book has minimal sales on Amazon.
Not enough insights yet.